Simplex Trading’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $62.2K | Buy |
+17,724
| New | +$72.6K | ﹤0.01% | 5625 |
|
|
2025
Q4 | – | Sell |
-20,739
| Closed | -$27K | – | 9278 |
|
|
2025
Q3 | $27K | Buy |
20,739
+19,963
| +2,573% | +$20.7K | ﹤0.01% | 7069 |
|
|
2025
Q2 | $0 | Sell |
776
-1,703
| -69% | -$1.34K | ﹤0.01% | 9173 |
|
|
2025
Q1 | $3K | Sell |
2,479
-2,881
| -54% | -$6.86K | ﹤0.01% | 7822 |
|
|
2024
Q4 | $23K | Sell |
5,360
-3,467
| -39% | -$14.1K | ﹤0.01% | 6571 |
|
|
2024
Q3 | $36K | Buy |
+8,827
| New | +$47.5K | ﹤0.01% | 6185 |
|
|
2023
Q4 | – | Sell |
-15,318
| Closed | -$152K | – | 9304 |
|
|
2023
Q3 | $147K | Buy |
15,318
+7,372
| +93% | +$72.3K | ﹤0.01% | 4679 |
|
|
2023
Q2 | $84K | Buy |
+7,946
| New | +$85.4K | ﹤0.01% | 5291 |
|
|
2022
Q3 | – | Sell |
-6,079
| Closed | -$68.9K | – | 10373 |
|
|
2022
Q2 | $70K | Buy |
6,079
+5,865
| +2,741% | +$69.1K | ﹤0.01% | 6043 |
|
|
2022
Q1 | $2K | Buy |
+214
| New | +$2.45K | ﹤0.01% | 9861 |
|
|
2021
Q4 | – | Sell |
-41,525
| Closed | -$509K | – | 10913 |
|
|
2021
Q3 | $536K | Sell |
41,525
-4,094
| -9% | -$52.9K | ﹤0.01% | 3994 |
|
|
2021
Q2 | $587K | Sell |
45,619
-18,318
| -29% | -$210K | ﹤0.01% | 3902 |
|
|
2021
Q1 | $714K | Buy |
+63,937
| New | +$675K | ﹤0.01% | 2852 |
|
|
2020
Q4 | – | Sell |
-21,640
| Closed | -$237K | – | 8682 |
|
|
2020
Q3 | $194K | Sell |
21,640
-45,866
| -68% | -$456K | ﹤0.01% | 4150 |
|
|
2020
Q2 | $696K | Buy |
67,506
+45,921
| +213% | +$470K | ﹤0.01% | 2497 |
|
|
2020
Q1 | $217K | Buy |
21,585
+16,028
| +288% | +$188K | ﹤0.01% | 3497 |
|
|
2019
Q4 | $73K | Buy |
+5,557
| New | +$61.3K | ﹤0.01% | 4839 |
|
|
2019
Q2 | – | Sell |
-1,110
| Closed | -$12.4K | – | 7424 |
|
|
2019
Q1 | $12K | Sell |
1,110
-7,907
| -88% | -$88.3K | ﹤0.01% | 6047 |
|
|
2018
Q4 | $78K | Buy |
9,017
+2,522
| +39% | +$28.9K | ﹤0.01% | 4091 |
|
|
2018
Q3 | $100K | Buy |
+6,495
| New | +$103K | ﹤0.01% | 4430 |
|
|
2018
Q2 | – | Sell |
-48,273
| Closed | -$714K | – | 7609 |
|
|
2018
Q1 | $623K | Buy |
48,273
+39,273
| +436% | +$489K | 0.03% | 608 |
|
|
2017
Q4 | $112K | Buy |
9,000
+5,818
| +183% | +$76K | ﹤0.01% | 1713 |
|
|
2017
Q3 | $42K | Sell |
3,182
-6,203
| -66% | -$85.4K | ﹤0.01% | 2464 |
|
|
2017
Q2 | $148K | Buy |
9,385
+6,042
| +181% | +$87.8K | 0.01% | 1429 |
|
|
2017
Q1 | $47K | Buy |
+3,343
| New | +$45.7K | ﹤0.01% | 2429 |
|
|
2016
Q3 | – | Sell |
-17,103
| Closed | -$200K | – | 6107 |
|
|
2016
Q2 | $187K | Buy |
+17,103
| New | +$167K | 0.01% | 1045 |
|
|
2016
Q1 | – | Sell |
-296
| Closed | -$2.44K | – | 5892 |
|
|
2015
Q4 | $2K | Sell |
296
-2,352
| -89% | -$22.7K | ﹤0.01% | 4512 |
|
|
2015
Q3 | $23K | Buy |
2,648
+2,314
| +693% | +$21.6K | ﹤0.01% | 2649 |
|
|
2015
Q2 | $3K | Sell |
334
-1,813
| -84% | -$21.1K | ﹤0.01% | 4047 |
|
|
2015
Q1 | $28K | Buy |
+2,147
| New | +$28.2K | ﹤0.01% | 2035 |
|
Other funds holding IRWD
AC
SCM
VPM
VCM
Simplex Trading's IRWD Position: Q1 2026 in Review
Simplex Trading opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2026: 17,724 shares worth $62.2K. The stake represents ﹤0.01% of the portfolio and ranks #5625 among its holdings. This is a return to the name: Simplex Trading previously reported a position in IRWD as recently as Q3 2025.
Simplex Trading first reported a position in IRWD in Q1 2015 and has held it in 30 quarters since. The position peaked at $714K in Q1 2021. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- Simplex Trading held 17,724 shares of Ironwood Pharmaceuticals worth $62.2K as of Q1 2026.
- Ironwood Pharmaceuticals was a new Simplex Trading position in Q1 2026.
- Ironwood Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5625 holding.
- Simplex Trading first reported a position in Ironwood Pharmaceuticals in Q1 2015 and has held it in 30 quarters since.
- Simplex Trading's Ironwood Pharmaceuticals position peaked at $714K in Q1 2021.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.